ARCHIVES
VOL. 13, ISSUE 1 (2026)
Animal studies on coumestrol: Metabolism, pharmacokinetics, and systemic health effects
Authors
Sonu Prajapati, Dr. Somkant V Jawarkar
Abstract
Coumestrol is a naturally occurring phytoestrogen
belonging to the coumestans class, widely present in legumes such as alfalfa,
clover, and soybean sprouts. Increasing interest in Coumestrol as a dietary
supplement has emerged due to its reported antioxidant, estrogenic, and
metabolic regulatory properties. However, comprehensive preclinical evidence
addressing its absorption, distribution, metabolism, and excretion (ADME), as
well as its systemic safety profile, remains limited. This review critically
evaluates available animal studies investigating the metabolic fate and health
effects of Coumestrol, with a particular focus on rodent models. Key endpoints
include pharmacokinetics, liver and kidney function, glucose and lipid
metabolism, inflammatory and oxidative stress markers, and histopathological
outcomes. Ethical and regulatory considerations, study design strategies, and
translational relevance to human research are also discussed. Collectively,
existing data suggest that orally administered Coumestrol undergoes predictable
metabolism, exhibits dose-dependent systemic exposure, and is generally well
tolerated at nutritionally relevant doses. Moreover, evidence indicates
potential metabolic benefits, including improved lipid homeostasis and insulin
sensitivity, supporting further controlled human investigations.
Download
Pages:635-638
How to cite this article:
Sonu Prajapati, Dr. Somkant V Jawarkar "Animal studies on coumestrol: Metabolism, pharmacokinetics, and systemic health effects". International Journal of Multidisciplinary Research and Development, Vol 13, Issue 1, 2026, Pages 635-638
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.
